RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Project Detail
Identification of a potential new prognostic biomarker to select IBD patients that fail standard therapy.
 
Team
Salomé Pinho (PI), Ana Dias, Francisco Liberal, Inês Alves, Márcia Pereira, Sandra Carvalho
 
Sponsor
Abbvie Lda (pharma)
 
Dates and Lifetime
From: 2014-07-01 To: 2016-12-31
Duration: 32 months
 
Reference
ABBVIE1
  
 
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject